Published in Gene Therapy Weekly, January 26th, 2006
"Exaeris is focusing on the direction and execution of commercial activities independent of Inyx's client manufacturing operations," said Jack Kachkar, MD, chairman & CEO of Inyx.
"Through Exaeris, we will build the necessary commercial resources to drive additional revenues and benefits to Inyx and our industry partners," Kachkar added.
Stephen Beckman, vice president sales & marketing and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.